These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26844789)

  • 21. Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age.
    Grzeskowiak LE; Gilbert AL; Sørensen TI; Olsen J; Sørensen HT; Pedersen LH; Morrison JL
    Ann Epidemiol; 2013 Nov; 23(11):681-7. PubMed ID: 24113367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring.
    Salari AA; Fatehi-Gharehlar L; Motayagheni N; Homberg JR
    Behav Brain Res; 2016 Sep; 311():354-367. PubMed ID: 27263073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective serotonin reuptake inhibitors in pediatric psychopharmacology: a review of the evidence.
    Hammerness PG; Vivas FM; Geller DA
    J Pediatr; 2006 Feb; 148(2):158-65. PubMed ID: 16492422
    [No Abstract]   [Full Text] [Related]  

  • 24. Antenatal depression and anxiety affect postpartum parenting stress: a longitudinal, prospective study.
    Misri S; Kendrick K; Oberlander TF; Norris S; Tomfohr L; Zhang H; Grunau RE
    Can J Psychiatry; 2010 Apr; 55(4):222-8. PubMed ID: 20416145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL; Kim DR; Epperson CN
    Psychopharmacology (Berl); 2013 Jun; 227(4):567-82. PubMed ID: 23681158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy.
    Vavasour E
    Pediatrics; 2004 Jul; 114(1):325. PubMed ID: 15231956
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation between prenatal maternal mood and anxiety and neonatal health.
    Misri S; Oberlander TF; Fairbrother N; Carter D; Ryan D; Kuan AJ; Reebye P
    Can J Psychiatry; 2004 Oct; 49(10):684-9. PubMed ID: 15560315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biopsychosocial determinants of treatment outcome for mood and anxiety disorders up to 8 months postpartum.
    Misri S; Albert G; Abizadeh J; Kendrick K; Carter D; Ryan D; Oberlander TF
    Arch Womens Ment Health; 2012 Aug; 15(4):313-6. PubMed ID: 22729759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anxiety and depression: which antidepressants treat both at the same time?].
    Laflamme F
    Perspect Infirm; 2010; 7(2):43. PubMed ID: 21744603
    [No Abstract]   [Full Text] [Related]  

  • 30. Major depression during conception and pregnancy: a guide for patients and families.
    Kahn DA; Moline ML; Ross RW; Cohen LS; Altshuler LL
    Postgrad Med; 2001 Mar; (Spec No):110-1. PubMed ID: 11500999
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing common Side effects of SSRIs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2007 Feb; 45(2):15-8. PubMed ID: 17334198
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of SSRIs in pregnancy: neonatal implications.
    Courtney K
    Nurs Womens Health; 2009 Jun; 13(3):234-8. PubMed ID: 19523137
    [No Abstract]   [Full Text] [Related]  

  • 33. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine treatment of social anxiety disorder with comorbid major depression.
    Lin CC
    J Clin Psychopharmacol; 2008 Oct; 28(5):591-2; author reply 592-3. PubMed ID: 18794669
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal infant EEG bursts are altered by prenatal maternal depression and serotonin selective reuptake inhibitor use.
    Grieve PG; Fifer WP; Cousy NP; Monk CE; Stark RI; Gingrich JA; Myers MM
    Clin Neurophysiol; 2019 Nov; 130(11):2019-2025. PubMed ID: 31539768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose.
    Roca A; Garcia-Esteve L; Imaz ML; Torres A; Hernández S; Botet F; Gelabert E; Subirà S; Plaza A; Valdés M; Martin-Santos R
    J Affect Disord; 2011 Dec; 135(1-3):208-15. PubMed ID: 21890210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parsing risk for the use of selective serotonin reuptake inhibitors in pregnancy.
    Yonkers KA
    Am J Psychiatry; 2009 Mar; 166(3):268-70. PubMed ID: 19255046
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal exposure to serotonin reuptake inhibitors: a case report.
    Marsella M; Ubaldini E; Solinas A; Guerrini P
    Ital J Pediatr; 2010 Mar; 36():27. PubMed ID: 20302650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressant use and preterm birth.
    Urato AC
    Am J Psychiatry; 2009 Oct; 166(10):1189; author reply 1189-90. PubMed ID: 19797450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.